Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis

NCT: NCT07592403 · RECRUITING

NCT IDNCT07592403
StatusRECRUITING
Start Date2026-05-16
Completion2027-01-30

Brief Summary

This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.

Frequently Asked Questions

What is Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis?

Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis is a clinical trial registered under NCT07592403. Current status: RECRUITING.

What is the status of NCT07592403?

The current status of NCT07592403 (Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis) is: RECRUITING.

When did Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis start?

Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis started on 2026-05-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.